Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections. - Geremia N; Giovagnorio F; Vena A; Corcione S; Giannella M; Pinna SM; Giovannenze F; Pascale R; Bavaro DF; Brusasco B; Scaglione V; Mikulska M; et al. (Infection, 2025)